Causal analysis between gastroesophageal reflux disease and chronic rhinosinusitis
- PMID: 38189968
- DOI: 10.1007/s00405-023-08350-w
Causal analysis between gastroesophageal reflux disease and chronic rhinosinusitis
Abstract
Background: Gastroesophageal reflux disease (GERD) and chronic rhinosinusitis (CRS) have been shown to be potentially closely related, but the relationship between these conditions, particularly the possibility of a causal link, is not fully understood. This study used Mendelian randomization (MR) to assess the causal relationship between these two disorders.
Methods: We extracted genome-wide association study data sets for GERD and CRS from publicly available gene summaries, and used MR to conduct a causal inference analysis. The main robustness test used in this study included MR-Egger regression, a leave-one-out sensitivity test, and multivariate MR (MVMR).
Results: GERD increased the risk of developing CRS by 36%, based on the inverse-variance weighted method, a statistically significant association (odds ratio [OR] 1.360, 95% confidence interval [CI] 1.179-1.568, P < 0.001). Other MR assessment methods, such as weighted median, simple mode, and weighted mode, similarly observed a significant increase in the risk of CRS occurrence (OR 1.434, 95% CI 1.186-1.734, P < 0.001; OR 1.927, 95% CI 1.166-3.184, P = 0.013; and OR 1.910, 95% CI 1.222-2.983, P = 0.006, respectively). No significant bias was found in the heterogeneity or pleiotropy tests (P = 0.071 and P = 0.700, respectively). Even after excluding possible mediators using MVMR, GERD appeared to significantly increase the risk of developing CRS (OR 1.013, 95% CI 1.008-1.023, P = 0.002).
Conclusions: This study provides new, significant evidence that GERD is genetically associated with a higher incidence rate of CRS. However, further research is needed to elucidate the potential underlying biological mechanisms of this relationship.
Keywords: Association; Chronic rhinosinusitis; Gastroesophageal reflux disease; Genome-wide association studies; Mendelian randomization.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Gastroesophageal reflux disease, laryngopharyngeal reflux, and nasopharyngeal reflux in chronic rhinosinusitis patients.Eur Arch Otorhinolaryngol. 2024 Jun;281(6):3295-3296. doi: 10.1007/s00405-024-08510-6. Epub 2024 Feb 15. Eur Arch Otorhinolaryngol. 2024. PMID: 38358508 No abstract available.
Similar articles
-
Gastroesophageal Reflux and Chronic Rhinosinusitis: A Mendelian Randomization Study.Laryngoscope. 2024 Jul;134(7):3086-3092. doi: 10.1002/lary.31258. Epub 2024 Jan 4. Laryngoscope. 2024. PMID: 38174811
-
Causal Effects of Gastroesophageal Reflux on Chronic Rhinosinusitis: A Bidirectional Two-Sample Mendelian Randomization Study.Clin Otolaryngol. 2025 Mar;50(2):280-287. doi: 10.1111/coa.14251. Epub 2024 Nov 3. Clin Otolaryngol. 2025. PMID: 39492462
-
Gastroesophageal Reflux Disease and Rhinosinusitis: A Bidirectional Mendelian Randomization Study.Int Arch Allergy Immunol. 2024;185(2):182-189. doi: 10.1159/000534676. Epub 2023 Nov 17. Int Arch Allergy Immunol. 2024. PMID: 37980884
-
Gastroesophageal reflux and rhinosinusitis.Curr Allergy Asthma Rep. 2013 Apr;13(2):218-23. doi: 10.1007/s11882-013-0340-5. Curr Allergy Asthma Rep. 2013. PMID: 23371037 Review.
-
Is there evidence to link acid reflux with chronic sinusitis or any nasal symptoms? A review of the evidence.Rhinology. 2011 Mar;49(1):11-6. doi: 10.4193/Rhino10.054. Rhinology. 2011. PMID: 21468368 Review.
Cited by
-
The Diagnostic Accuracy of the Nasopharyngeal Reflux Endoscopic Score (NRES) for Identifying Laryngopharyngeal Reflux Disease in Chronic Rhinosinusitis.J Clin Med. 2025 Jun 17;14(12):4293. doi: 10.3390/jcm14124293. J Clin Med. 2025. PMID: 40566038 Free PMC article.
-
Endoscopic Features of Chronic Rhinosinusitis in Patients with Gastroesophageal Reflux Disease.Medicina (Kaunas). 2024 Aug 2;60(8):1257. doi: 10.3390/medicina60081257. Medicina (Kaunas). 2024. PMID: 39202538 Free PMC article.
References
-
- Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN, Bröker BM, Laidlaw T, Song WJ (2020) Adult chronic rhinosinusitis. Nat Rev Dis Primers 6(1):86. https://doi.org/10.1038/s41572-020-00218-1 - DOI - PubMed
-
- Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet (London, England) 394(10209):1638–1650. https://doi.org/10.1016/S0140-6736(19)31881-1IF:202.731Q1 - DOI - PubMed
-
- Hoggard M, Wagner Mackenzie B, Jain R, Taylor MW, Biswas K, Douglas RG (2017) Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease. Clin Microbiol Rev 30(1):321–348. https://doi.org/10.1128/CMR.00060-16 - DOI - PubMed
-
- Kennedy DW (2004) Pathogenesis of chronic rhinosinusitis. Ann Otol Rhinol Laryngol 193:6–9. https://doi.org/10.1177/00034894041130s503IF:1.973Q3 - DOI
-
- Ceballos Cantu JC, Alobid I, Mullol J (2022) chronic rhinosinusitis in a population of patients with gastroesophageal reflux disease. Expert Rev Clin Immunol 18(12):1253–1263. https://doi.org/10.1080/1744666X.2022.2128767 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical